Steamed root of Rehmannia glutinosa Libosch (Plantaginaceae) alleviates methotrexate-induced intestinal mucositis in rats

被引:22
作者
Shi, Cheng-jin [1 ]
Wen, Xue-Sen [1 ]
Gao, Hui-feng [1 ]
Liu, Zhi-hua [1 ]
Xu, Xu-kang [2 ]
Li, Li-fen [1 ]
Shen, Tao [1 ]
Xian, Cory J. [2 ]
机构
[1] Shandong Univ, Inst Pharmacognosy, Sch Pharmaceut Sci, Jinan 250012, Peoples R China
[2] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia
基金
澳大利亚国家健康与医学研究理事会; 中国国家自然科学基金;
关键词
Rehmannia glutinosa; Mucositis; Leucopenia; Methotrexate; Chemotherapy; Calcium folinate; PRO-INFLAMMATORY CYTOKINES; VOLUME/PLATELET COUNT RATIO; ALIMENTARY-TRACT MUCOSITIS; INDUCED ORAL MUCOSITIS; MEAN PLATELET VOLUME; NF-KAPPA-B; OXIDATIVE STRESS; CANCER-TREATMENT; FOLINIC ACID; CHEMOTHERAPY;
D O I
10.1016/j.jep.2016.02.035
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Intestinal mucositis induced by chemotherapy is a severe clinical problem in cancer patients that currently lack effective interventions. In traditional Chinese medicine, chemotherapeutic toxicity is diagnosed as Qi and Yin deficiency, and steamed rehmannia root (SRR) is frequently prescribed to these patients. Whether SRR can prevent the adverse effects remains to be confirmed experimentally. The present study used a rat model to investigate potential efficacy and action mechanisms of SRR in attenuating the adverse effects caused by chemotherapy. Materials and methods: Intraperitoneal injection of a single dose of anti-metabolite methotrexate (MTX, 25 mg/kg) was given to adult Wistar rats, which also received oral gavage of water or SRR (1.08 g/kg twice daily 3 days before and 4 days after MTX treatment), or calcium folinate (CF, a clinically used MTX antidote as a comparison, at 1 mg/kg twice daily 36 h after MTX treatment), or SRR and CF in combination. Animals were sacrificed 4 days after MTX treatment. Complete blood cell counting was carried out. Jejunum was analyzed histologically for mucosal damage, immunohistochemically for proliferating cell nuclear antigen (PCNA), and biochemically for thiobarbituric acid reactive substances (TBARS) and reduced glutathione (GSH), as well as for tumor necrosis factor alpha (TNF-alpha). Results: MTX treatment led to weight loss, leucopenia, polycythemia, increase in large thrombocyte ratio, intestinal villus atrophy, crypt loss and reduction in PCNA positive crypt cells, increases in mucosal TBARS and TNF-alpha and decrease in GSH. All these alterations were inhibited by SRR administration except leucopenia, and the effects of CF or CF plus SRR supplementation were found to be inferior to those of SRR. Conclusions: SRR can alleviate MTX-induced gut mucositis, which may be achieved by inhibiting MIX-induced oxidative stress and inflammatory response. These findings support the application of SRR in chemotherapy but not the combined application of SRR and CF. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:143 / 150
页数:8
相关论文
共 84 条
[1]   Emerging evidence on the pathobiology of mucositis [J].
Al-Dasooqi, Noor ;
Sonis, Stephen T. ;
Bowen, Joanne M. ;
Bateman, Emma ;
Blijlevens, Nicole ;
Gibson, Rachel J. ;
Logan, Richard M. ;
Nair, Raj G. ;
Stringer, Andrea M. ;
Yazbeck, Roger ;
Elad, Sharon ;
Lalla, Rajesh V. .
SUPPORTIVE CARE IN CANCER, 2013, 21 (07) :2075-2083
[2]   Beneficial effects of cathepsin inhibition to prevent chemotherapy-induced intestinal mucositis [J].
Alamir, I. ;
Boukhettala, N. ;
Aziz, M. ;
Breuille, D. ;
Dechelotte, P. ;
Coeffier, M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 162 (02) :298-305
[3]  
[Anonymous], 2012, Asian J Tradit Med
[4]   The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test [J].
Choi, Kwon ;
Lee, Seung Sei ;
Oh, Suk Joong ;
Lim, Seong Yong ;
Lim, Si Young ;
Jeon, Woo Kyu ;
Oh, Tae Yun ;
Kim, Jeong Wook .
CLINICAL NUTRITION, 2007, 26 (01) :57-62
[5]   Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms [J].
Cleeland, CS ;
Bennett, GJ ;
Dantzer, R ;
Dougherty, PM ;
Dunn, AJ ;
Meyers, CA ;
Miller, AH ;
Payne, R ;
Reuben, JM ;
Wang, XS ;
Lee, BN .
CANCER, 2003, 97 (11) :2919-2925
[6]   Chemotherapy-induced neutropenia - Risks, consequences, and new directions for its management [J].
Crawford, J ;
Dale, DC ;
Lyman, GH .
CANCER, 2004, 100 (02) :228-237
[7]   Concurrent decline of several antioxidants and markers of oxidative stress during combination chemotherapy for small cell lung cancer [J].
Crohns, Marika ;
Liippo, Kari ;
Erhola, Marina ;
Kankaanranta, Hannu ;
Moilanen, Eeva ;
Alho, Hannu ;
Kellokumpu-Lehtinen, Pirkko .
CLINICAL BIOCHEMISTRY, 2009, 42 (12) :1236-1245
[8]   Platelet-Large Cell Ratio and the extent of coronary artery disease: results from a large prospective study [J].
De Luca, Giuseppe ;
Santagostino, Matteo ;
Secco, Gioel Gabrio ;
Cassetti, Ettore ;
Giuliani, Livio ;
Coppo, Lorenzo ;
Schaffer, Alon ;
Fundaliotis, Angelica ;
Iorio, Sergio ;
Venegoni, Luca ;
Bellomo, Giorgio ;
Marino, Paolo .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 30 (04) :426-433
[9]   Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis [J].
Fan, C. ;
Foster, B. K. ;
Wallace, W. H. ;
Xian, C. J. .
CURRENT MOLECULAR MEDICINE, 2011, 11 (02) :140-151
[10]   Prevention of Bone Growth Defects, Increased Bone Resorption and Marrow Adiposity with Folinic Acid in Rats Receiving Long-Term Methotrexate [J].
Fan, Chia-Ming ;
Foster, Bruce K. ;
Hui, Susanta K. ;
Xian, Cory J. .
PLOS ONE, 2012, 7 (10)